Navigation Links
BPSA's 3rd Annual Summit to Focus on Next Decade for Single-Use Biomanufacturing

WASHINGTON, May 28, 2013 /PRNewswire-USNewswire/ -- The Bio-Process Systems Alliance (BPSA) is pleased to announce the 3rd annual International Single-Use Summit (ISUS 2013) will be held July 15-17, 2013, in Washington, D.C. The slate of speakers for this year's event will offer insight on the next decade for single-use systems in biopharmaceutical manufacturing, including economics, standardization, workforce challenges, innovation and globalization.

Doug Neugold , Chairman of the Board, CEO and President of ATMI, a global leader in enabling process materials and process technology for semiconductor, display and life science industries, will be the keynote speaker. Neugold will share his perspective on the challenges of innovating and advancing new technologies in a dynamic global economy by drawing from lessons learned in the semiconductor industry. 

Ralph S. Tyler , immediate-past chief counsel for the Food and Drug Administration (FDA) who is now with Venable LLP, will talk about what can be expected from the FDA over the next four years, including enforcement, compliance and globalization. In his role with the FDA, Tyler was responsible for the advice and representation of the agency in counseling, litigation and enforcement matters across the product areas within the FDA's jurisdiction.

"Our program committee has succeeded in building a hard-hitting agenda of discussion and commentary on business issues that will impact the rates of adoption and growth of single-use in pharmaceutical manufacture," said Jerold Martin , Senior Vice President of Pall Life Sciences and Chairman of the BPSA board.

Speakers will also share perspectives on Wall Street and the deficit/sequester effect on the U.S. economy and its impact on the biopharmaceutical industry, and experts will examine management challenges evident in today's four generations workplace, specifically the Millennial Generation.

An overview of single-use market trends and the results of the latest Single-Use End User Survey will be presented by BioPlan Associates and Bio-Process International representatives.

A significant portion of the summit agenda will be dedicated to topic panels on particulates, proposed extractable test condition protocols impacting the supplier base, as well as supply chain security. These panels will address definitions, regulations and industry expectations (both user and supplier perspectives) on these key issues, resulting in concrete industry action plans moving forward. 

The event will be held at the Four Seasons Hotel Georgetown in Washington, D.C. Full agenda, registration and hotel information can be viewed at

About BPSA

The Bio-Process Systems Alliance (BPSA) was formed in 2005 as an industry-led corporate member trade association dedicated to encouraging and accelerating the adoption of single-use manufacturing technologies used in the production of biopharmaceuticals and vaccines. BPSA facilitates education, sharing of best practices, development of consensus guides and business-to-business networking opportunities among its member company employees. For more information, please visit, or contact Kevin Ott , Executive Director, at

Kevin Ott , Executive Director

SOURCE Bio-Process Systems Alliance (BPSA)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. 20th Annual National Senior Health & Fitness Day Set for Wednesday, May 29
2. DelMar Pharmaceuticals to Present Clinical Trials Data for VAL-083 Brain Cancer Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
3. BD to Present at the Deutsche Bank 38th Annual Health Care Conference
4. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
5. Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference
6. Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference
7. Amgen to Present at the Deutsche Bank 38th Annual Healthcare Conference
8. Haemonetics to Present at The Deutsche Bank 38th Annual dbAccess Health Care Conference
9. Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting
10. CASMED to Present at the 2nd Annual Marcum MicroCap Conference
11. Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
Post Your Comments:
(Date:12/1/2015)... 2015 Breg, Inc ., a premier ... that it has been awarded three contracts by Novation, ... Novation will have access to improved pricing for Breg,s ... soft goods dedicated to advancing orthopedic care.  ... U.S. population, rising prevalence of chronic conditions and the ...
(Date:12/1/2015)... , December 1, 2015 Russia ... III clinical trials. 70% of new drugs registered in Europe ... in Russia . --> Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a ...
(Date:12/1/2015)... 1, 2015 CytRx Corporation (NASDAQ: CYTR ... oncology, today announced that it has reached its enrollment ... Phase 3 clinical trial of aldoxorubicin in patients with ... to be completed in Q1 2016. The Phase 3 trial ... Special Protocol Assessment from the FDA at 79 sites ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... , ... Integrated Rental Services (“Integrated Rental”), a growing medical ... , With support from JII, Integrated Rental is poised for expansion while improving ... research labs and medical facilities across the United States. , General Manager Robert ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... Califia ... today announced that its iconic bottle has won top honors in Beverage World Magazine’s ... The Company also announced that it has been selected as a 2015 U.S.A. Taste ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... we have seen vast improvements in scientific research and discoveries, leading us to ... increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s cross-platform edition of ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of ... is the focus of numerous abstracts accepted for presentation here, at the 101st ... Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next ... selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an ... was recognized as a finalist in the category of Digital Solutions for its ...
Breaking Medicine News(10 mins):